search
Back to results

Zambia Exclusive Breastfeeding Study

Primary Purpose

HIV Infection

Status
Completed
Phase
Not Applicable
Locations
Zambia
Study Type
Interventional
Intervention
abrupt weaning at 4 months
Continued exclusive breastfeeding
Sponsored by
Boston Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV Infection focused on measuring Mother to Child Transmission of HIV, Postnatal HIV transmission, HIV, Breastfeeding, Perinatal HIV Transmission, HIV Seronegativity

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: HIV-positive pregnant women identified through VCT After counseling about the risks and benefits of feeding alternatives report that it is their intended decision to breastfeed Live within the catchment area of George or Chawama clinic Are between 30 - 34 wks gestation. (To insure that opportunity exists to receive a minimum of 2 lactation counseling sessions prior to delivery) Do not have any significant presenting illness that requires hospitalization Agree to adhere to the requirements of study participation (including exclusive breastfeeding and randomization into one of two infant feeding groups at four months). Willing to inform a household member (preferably husband/father) of HIV-status. Exclusion Criteria: Lives outside of catchment area; Have known major illnesses likely to influence pregnancy outcome including diabetes, severe renal or heart disease, or active tuberculosis, prior to randomization; Does not intend to breastfeed; Prior enrollment in this study or concurrent enrollment in another study

Sites / Locations

  • George and Chawama District Health Clinics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Abrupt Weaning

Exclusive breastfeeding per WHO guidelines

Arm Description

Women were counseled to abruptly wean their child at 4 months of age.

Women were counseled to adhere to the WHO recommendations for duration of exclusive breastfeeding.

Outcomes

Primary Outcome Measures

HIV infection detected by 4 months among children with no evidence of HIV infection at birth.
Magnitude of the reduction in mother-to-child HIV transmission and the magnitude of the increase in non-HIV-related under-2-year mortality, attributable to cessation of breastfeeding at 4 months.

Secondary Outcome Measures

Full Information

First Posted
April 3, 2006
Last Updated
July 26, 2011
Sponsor
Boston Medical Center
Collaborators
United States Agency for International Development (USAID), National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT00310726
Brief Title
Zambia Exclusive Breastfeeding Study
Official Title
Short Duration Exclusive Breastfeeding With Abrupt Weaning to Reduce the Risk of Mother-to-Child HIV Transmission
Study Type
Interventional

2. Study Status

Record Verification Date
July 2011
Overall Recruitment Status
Completed
Study Start Date
May 2001 (undefined)
Primary Completion Date
December 2006 (Actual)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Boston Medical Center
Collaborators
United States Agency for International Development (USAID), National Institutes of Health (NIH)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study is designed as a randomized, controlled trial with specific observational objectives. All HIV-seropositive pregnant subjects electing to breastfeed their child will be counselled to exclusively breastfeed through 4 months of age. All live-born children will be randomized (1:1) at birth to one of two counseling programs: A) to encourage abrupt weaning at 4 months of age, or B) to encourage exclusive breastfeeding through 6 months of age with the introduction of typical weaning foods ad lib.
Detailed Description
It is well established that infants breast fed by their HIV-infected mothers are at risk of acquiring HIV infection through breast milk. However, in low resource settings, where the HIV epidemic now predominates, breast feeding cannot simply be replaced by breast milk substitutes since alternatives to breast milk are unavailable, unaffordable and unsafe. With this application we aim to test the safety and efficacy of short duration exclusive breast feeding to minimize risks of HIV transmission without increasing risks of non-HIV infant mortality. We propose a 5-year study of HIV-positive mothers and their children to be conducted in two urban primary health care clinics in Lusaka, Zambia. All HIV-positive women and their infants will be offered the two-dose nevirapine intervention and will be counseled about the risks and benefits of infant feeding options. Women who indicate their decision to breast feed will be eligible for enrollment into the study. A culturally appropriate, affordable and sustainable breast feeding education and support program to encourage exclusive breast feeding will be developed, and all women who elect to breast feed will be encouraged to exclusively breast feed to 4 months. Half of the women will be randomized to a counseling program which will encourage abrupt weaning to full replacement feeding at 4 months, and half will be randomized to a program to encourage continued breast feeding after 4 months with the usual introduction of weaning foods. Children will be followed for two years with regular medical histories, physical exams and clinical sampling. The primary objective of the study, based on the random assignment, is to compare HIV transmission rates and under-2 year mortality rates in children who abruptly wean at four months of age versus children who are weaned according to local practice. The second primary objective, based on observational comparisons, is to compare HIV transmission among infants whose mothers adhere to recommendations to exclusively breast feed with those who do not. Secondary objectives are to describe acute and chronic effects of abrupt weaning on child morbidity. The study proposes to test an inexpensive and potentially sustainable public health intervention to reduce HIV transmission through breast feeding while preserving benefits of breast feeding for other aspects of child health in a very low resource setting.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infection
Keywords
Mother to Child Transmission of HIV, Postnatal HIV transmission, HIV, Breastfeeding, Perinatal HIV Transmission, HIV Seronegativity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1435 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Abrupt Weaning
Arm Type
Experimental
Arm Description
Women were counseled to abruptly wean their child at 4 months of age.
Arm Title
Exclusive breastfeeding per WHO guidelines
Arm Type
Active Comparator
Arm Description
Women were counseled to adhere to the WHO recommendations for duration of exclusive breastfeeding.
Intervention Type
Other
Intervention Name(s)
abrupt weaning at 4 months
Intervention Description
abrupt weaning at 4 months
Intervention Type
Other
Intervention Name(s)
Continued exclusive breastfeeding
Intervention Description
Continued exclusive breastfeeding
Primary Outcome Measure Information:
Title
HIV infection detected by 4 months among children with no evidence of HIV infection at birth.
Time Frame
24 months of age
Title
Magnitude of the reduction in mother-to-child HIV transmission and the magnitude of the increase in non-HIV-related under-2-year mortality, attributable to cessation of breastfeeding at 4 months.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: HIV-positive pregnant women identified through VCT After counseling about the risks and benefits of feeding alternatives report that it is their intended decision to breastfeed Live within the catchment area of George or Chawama clinic Are between 30 - 34 wks gestation. (To insure that opportunity exists to receive a minimum of 2 lactation counseling sessions prior to delivery) Do not have any significant presenting illness that requires hospitalization Agree to adhere to the requirements of study participation (including exclusive breastfeeding and randomization into one of two infant feeding groups at four months). Willing to inform a household member (preferably husband/father) of HIV-status. Exclusion Criteria: Lives outside of catchment area; Have known major illnesses likely to influence pregnancy outcome including diabetes, severe renal or heart disease, or active tuberculosis, prior to randomization; Does not intend to breastfeed; Prior enrollment in this study or concurrent enrollment in another study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Louise Kuhn, PhD
Organizational Affiliation
Gertrude H. Sergievsky Center, and Department of Epidemiology, Mailman School of Public Health, Columbia University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Donald M Thea, MD, MSc
Organizational Affiliation
Department of International Health, Boston University School of Public Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
George and Chawama District Health Clinics
City
Lusaka
Country
Zambia

12. IPD Sharing Statement

Citations:
PubMed Identifier
15296810
Citation
Thea DM, Vwalika C, Kasonde P, Kankasa C, Sinkala M, Semrau K, Shutes E, Ayash C, Tsai WY, Aldrovandi G, Kuhn L. Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study. Control Clin Trials. 2004 Aug;25(4):353-65. doi: 10.1016/j.cct.2004.06.005.
Results Reference
background
PubMed Identifier
20568677
Citation
Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Mwiya M, Thea DM. Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to- child HIV transmission. AIDS. 2010 Jun 1;24(9):1374-7.
Results Reference
background
PubMed Identifier
16340483
Citation
Albrecht S, Semrau K, Kasonde P, Sinkala M, Kankasa C, Vwalika C, Aldrovandi GM, Thea DM, Kuhn L. Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):114-8. doi: 10.1097/01.qai.0000179425.27036.d7.
Results Reference
result
PubMed Identifier
16267740
Citation
Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Scott N, Tsai WY, Vermund SH, Aldrovandi GM, Thea DM. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis. 2005 Dec 1;41(11):1654-61. doi: 10.1086/498029. Epub 2005 Oct 27.
Results Reference
result
PubMed Identifier
16184038
Citation
Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Vwalika C, Tsai WY, Aldrovandi GM, Thea DM. Prolonged breast-feeding and mortality up to two years post-partum among HIV-positive women in Zambia. AIDS. 2005 Oct 14;19(15):1677-81. doi: 10.1097/01.aids.0000186817.38112.da.
Results Reference
result
PubMed Identifier
15905728
Citation
Kuhn L, Trabattoni D, Kankasa C, Semrau K, Kasonde P, Lissoni F, Sinkala M, Ghosh M, Vwalika C, Aldrovandi GM, Thea DM, Clerici M. Alpha-defensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):138-42.
Results Reference
result
PubMed Identifier
15802979
Citation
Semrau K, Kuhn L, Vwalika C, Kasonde P, Sinkala M, Kankasa C, Shutes E, Aldrovandi G, Thea DM. Women in couples antenatal HIV counseling and testing are not more likely to report adverse social events. AIDS. 2005 Mar 24;19(6):603-9. doi: 10.1097/01.aids.0000163937.07026.a0.
Results Reference
result
PubMed Identifier
12791866
Citation
Ghosh MK, Kuhn L, West J, Semrau K, Decker D, Thea DM, Aldrovandi GM. Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol. 2003 Jun;41(6):2465-70. doi: 10.1128/JCM.41.6.2465-2470.2003.
Results Reference
result
PubMed Identifier
12097549
Citation
Sabbaj S, Edwards BH, Ghosh MK, Semrau K, Cheelo S, Thea DM, Kuhn L, Ritter GD, Mulligan MJ, Goepfert PA, Aldrovandi GM. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol. 2002 Aug;76(15):7365-73. doi: 10.1128/jvi.76.15.7365-7373.2002.
Results Reference
result
PubMed Identifier
21459815
Citation
Fawzy A, Arpadi S, Kankasa C, Sinkala M, Mwiya M, Thea DM, Aldrovandi GM, Kuhn L. Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia. J Infect Dis. 2011 May 1;203(9):1222-30. doi: 10.1093/infdis/jir019.
Results Reference
result
PubMed Identifier
21173592
Citation
Gray RR, Salemi M, Lowe A, Nakamura KJ, Decker WD, Sinkala M, Kankasa C, Mulligan CJ, Thea DM, Kuhn L, Aldrovandi G, Goodenow MM. Multiple independent lineages of HIV-1 persist in breast milk and plasma. AIDS. 2011 Jan 14;25(2):143-52. doi: 10.1097/QAD.0b013e328340fdaf.
Results Reference
result
PubMed Identifier
20484334
Citation
Murnane PM, Arpadi SM, Sinkala M, Kankasa C, Mwiya M, Kasonde P, Thea DM, Aldrovandi GM, Kuhn L. Lactation-associated postpartum weight changes among HIV-infected women in Zambia. Int J Epidemiol. 2010 Oct;39(5):1299-310. doi: 10.1093/ije/dyq065. Epub 2010 May 19.
Results Reference
result
PubMed Identifier
20422033
Citation
Heath L, Conway S, Jones L, Semrau K, Nakamura K, Walter J, Decker WD, Hong J, Chen T, Heil M, Sinkala M, Kankasa C, Thea DM, Kuhn L, Mullins JI, Aldrovandi GM. Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS One. 2010 Apr 20;5(4):e10213. doi: 10.1371/journal.pone.0010213.
Results Reference
result
PubMed Identifier
20047479
Citation
Kuhn L, Sinkala M, Semrau K, Kankasa C, Kasonde P, Mwiya M, Hu CC, Tsai WY, Thea DM, Aldrovandi GM. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis. 2010 Feb 1;50(3):437-44. doi: 10.1086/649886.
Results Reference
result
PubMed Identifier
19835475
Citation
Walter J, Ghosh MK, Kuhn L, Semrau K, Sinkala M, Kankasa C, Thea DM, Aldrovandi GM. High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. J Infect Dis. 2009 Nov 15;200(10):1498-502. doi: 10.1086/644603.
Results Reference
result
PubMed Identifier
19625479
Citation
Walter J, Kuhn L, Semrau K, Decker DW, Sinkala M, Kankasa C, Thea DM, Bulterys M, Ou CY, Aldrovandi GM. Detection of low levels of human immunodeficiency virus (HIV) may be critical for early diagnosis of pediatric HIV infection by use of dried blood spots. J Clin Microbiol. 2009 Sep;47(9):2989-91. doi: 10.1128/JCM.02453-08. Epub 2009 Jul 22.
Results Reference
result
PubMed Identifier
19557167
Citation
Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Kasonde P, Mwiya M, Tsai WY, Thea DM; Zambia Exclusive Breastfeeding Study (ZEBS). Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease. PLoS One. 2009 Jun 26;4(6):e6059. doi: 10.1371/journal.pone.0006059.
Results Reference
result
PubMed Identifier
19553300
Citation
Arpadi S, Fawzy A, Aldrovandi GM, Kankasa C, Sinkala M, Mwiya M, Thea DM, Kuhn L. Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia. Am J Clin Nutr. 2009 Aug;90(2):344-53. doi: 10.3945/ajcn.2009.27745. Epub 2009 Jun 24.
Results Reference
result
PubMed Identifier
19506483
Citation
Kuhn L, Semrau K, Ramachandran S, Sinkala M, Scott N, Kasonde P, Mwiya M, Kankasa C, Decker D, Thea DM, Aldrovandi GM. Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):132-6. doi: 10.1097/QAI.0b013e3181ab6d5e.
Results Reference
result
PubMed Identifier
19116004
Citation
Walter J, Kuhn L, Kankasa C, Semrau K, Sinkala M, Thea DM, Aldrovandi GM. Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study. BMC Infect Dis. 2008 Dec 30;8:172. doi: 10.1186/1471-2334-8-172.
Results Reference
result
PubMed Identifier
19047077
Citation
Fox MP, Brooks DR, Kuhn L, Aldrovandi G, Sinkala M, Kankasa C, Horsburgh R, Thea DM. Role of breastfeeding cessation in mediating the relationship between maternal HIV disease stage and increased child mortality among HIV-exposed uninfected children. Int J Epidemiol. 2009 Apr;38(2):569-76. doi: 10.1093/ije/dyn249. Epub 2008 Nov 30.
Results Reference
result
PubMed Identifier
18525036
Citation
Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M, Kasonde P, Scott N, Vwalika C, Walter J, Bulterys M, Tsai WY, Thea DM; Zambia Exclusive Breastfeeding Study. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008 Jul 10;359(2):130-41. doi: 10.1056/NEJMoa073788. Epub 2008 Jun 4. Erratum In: N Engl J Med. 2008 Oct 23;359(17):1859.
Results Reference
result
PubMed Identifier
18398972
Citation
Semrau K, Ghosh M, Kankasa C, Sinkala M, Kasonde P, Mwiya M, Thea DM, Kuhn L, Aldrovandi GM. Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):320-8. doi: 10.1097/qai.0b013e31815e7436.
Results Reference
result
PubMed Identifier
18344878
Citation
Fox MP, Brooks D, Kuhn L, Aldrovandi G, Sinkala M, Kankasa C, Mwiya M, Horsburgh R, Thea DM. Reduced mortality associated with breast-feeding-acquired HIV infection and breast-feeding among HIV-infected children in Zambia. J Acquir Immune Defic Syndr. 2008 May 1;48(1):90-6. doi: 10.1097/QAI.0b013e31816e39a3.
Results Reference
result
PubMed Identifier
18159246
Citation
Kuhn L, Sinkala M, Kankasa C, Semrau K, Kasonde P, Scott N, Mwiya M, Vwalika C, Walter J, Tsai WY, Aldrovandi GM, Thea DM. High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS One. 2007 Dec 26;2(12):e1363. doi: 10.1371/journal.pone.0001363.
Results Reference
result
PubMed Identifier
17912348
Citation
Castelletti E, Lo Caputo S, Kuhn L, Borelli M, Gajardo J, Sinkala M, Trabattoni D, Kankasa C, Lauri E, Clivio A, Piacentini L, Bray DH, Aldrovandi GM, Thea DM, Veas F, Nebuloni M, Mazzotta F, Clerici M. The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection. PLoS One. 2007 Oct 3;2(10):e969. doi: 10.1371/journal.pone.0000969.
Results Reference
result
PubMed Identifier
33252547
Citation
Celerino da Silva R, Segat L, Kuhn L, Chies JAB, Crovella S. Association of SNPs in HLA-C and ZNRD1 Genes With HIV-1 Mother-to-Child Transmission in Zambia Population. J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):509-515. doi: 10.1097/QAI.0000000000002584.
Results Reference
derived
PubMed Identifier
22894939
Citation
Bode L, Kuhn L, Kim HY, Hsiao L, Nissan C, Sinkala M, Kankasa C, Mwiya M, Thea DM, Aldrovandi GM. Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding. Am J Clin Nutr. 2012 Oct;96(4):831-9. doi: 10.3945/ajcn.112.039503. Epub 2012 Aug 15.
Results Reference
derived

Learn more about this trial

Zambia Exclusive Breastfeeding Study

We'll reach out to this number within 24 hrs